I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
Efficacy and Effect on Liver Functional Reserve of Atezoliz..:
Takuya Sho
;
Goki Suda
;
Yoshiya Yamamoto
...
https://www.mdpi.com/2072-6694/14/16/3938. , 2022
Link:
https://doi.org/10.3390/cancers14163938
RT Journal T1
Efficacy and Effect on Liver Functional Reserve of Atezolizumab and Bevacizumab for Unresectable Hepatocellular Carcinoma in Patients Who Do Not Meet Eligibility Criteria of IMbrave150
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:84e45feb160847d2956997952d3026ee&Exemplar=1&LAN=DE A1 Takuya Sho A1 Goki Suda A1 Yoshiya Yamamoto A1 Ken Furuya A1 Masaru Baba A1 Koji Ogawa A1 Akinori Kubo A1 Yoshimasa Tokuchi A1 Qingjie Fu A1 Zijian Yang A1 Megumi Kimura A1 Takashi Kitagataya A1 Osamu Maehara A1 Shunsuke Ohnishi A1 Akihisa Nakamura A1 Ren Yamada A1 Masatsugu Ohara A1 Naoki Kawagishi A1 Mitsuteru Natsuizaka A1 Masato Nakai A1 Kazuharu Suzuki A1 Takaaki Izumi A1 Takashi Meguro A1 Katsumi Terashita A1 Tomofumi Takagi A1 Jun Ito A1 Tomoe Kobayashi A1 Takuto Miyagishima A1 Naoya Sakamoto PB MDPI AG YR 2022 K1 atezolizumab K1 bevacizumab K1 eligibility criteria of IMbrave150 K1 hepatocellular carcinoma K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://www.mdpi.com/2072-6694/14/16/3938 LK http://dx.doi.org/https://doi.org/10.3390/cancers14163938 DO https://doi.org/10.3390/cancers14163938 SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)